Primary endpoints met in phase III trial of Hisamitsu Pharmaceutical oxybutynin formulation Aug. 17, 2011
Watson Pharmaceuticals and Antares sign licensing agreement for Anturol gel in U.S. and Canada July 14, 2011
RSS